Trials / Completed
CompletedNCT02084069
Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Urmia University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the investigation is to determine whether Atrovastatin as anti-inflammatory agent can be effective in preventing from atrial fibrillation incidence in patients whom undergone open cardiac surgery for their heart valve repair.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2014-03-11
- Last updated
- 2015-03-04
- Results posted
- 2015-02-04
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT02084069. Inclusion in this directory is not an endorsement.